NewsDialy
Unusual market activity, meaning trading volume or price movement that departs from a company's normal pattern without a clear business reason, prompted a public statement from a Chinese pharmaceutical firm listed in New York.
(NYSE American: CPHI), headquartered in Haikou, China, said on July 15, 2026, that it is aware of the abnormal trading in its common stock and has found no internal cause for it.
What the company said China Pharma Holdings said it knows of no events that could have caused the unusual market activity in its shares. That is the full scope of the disclosure.
No executive was named, and no specific trading data was described.
Keep reading